购物车
- 全部删除
您的购物车当前为空
Anti-BLCAP Antibody (7F556)
还可以
产品编号 TMAC-00444
别名 BLCAP_HUMAN, BLCAP, Bladder cancer-associated protein, Bladder cancer related protein (10kD), Bladder cancer 10 kDa protein, Bc10
Anti-BLCAP Antibody (7F556) 是一种 Mouse 抗体，靶向 BLCAP。Anti-BLCAP Antibody (7F556) 可用于 WB,IHC,ICC。
Anti-BLCAP Antibody (7F556)
Anti-BLCAP Antibody (7F556)
还可以产品编号 TMAC-00444 别名 BLCAP_HUMAN, BLCAP, Bladder cancer-associated protein, Bladder cancer related protein (10kD), Bladder cancer 10 kDa protein, Bc10
Anti-BLCAP Antibody (7F556) 是一种 Mouse 抗体，靶向 BLCAP。Anti-BLCAP Antibody (7F556) 可用于 WB,IHC,ICC。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 μL | ¥ 1,980 | 5日内发货 | |
| 100 μL | ¥ 2,990 | 5日内发货 |
大包装 & 定制
加入购物车
TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。
联系我们获取更多批次信息
资源下载
产品介绍
生物活性
偶联与修饰
抗原信息
| 产品描述 | Anti-BLCAP Antibody (7F556) is a Mouse antibody targeting BLCAP. Anti-BLCAP Antibody (7F556) can be used in WB,IHC,ICC. |
| 别名 | BLCAP_HUMAN, BLCAP, Bladder cancer-associated protein, Bladder cancer related protein (10kD), Bladder cancer 10 kDa protein, Bc10 |
| 交叉反应 | Human,Rat |
| 验证活性 | 1. Western blot analysis of BLCAP on recombinant protein tissue lysate using anti-BLCAP antibody at 1/5,000 dilution. 2. Immunohistochemical analysis of paraffin-embedded human breast tissue using anti-BLCAP antibody. Counter stained with hematoxylin. 3. Immunohistochemical analysis of paraffin-embedded rat cervix tissue using anti-BLCAP antibody. Counter stained with hematoxylin. 4. ICC staining BLCAP (green) in HepG2 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS. |
| 应用 | |
| 推荐剂量 | WB: 1:1000-2000; IHC: 1:50-200; ICC: 1:50-200 |
| 抗体种类 | Monoclonal |
| 宿主来源 | Mouse |
| 构建方式 | Hybridoma Monoclonal Antibody |
| 纯化方式 | ProG affinity purified |
| 性状 | Liquid |
| 缓冲液 | 1*TBS (pH7.4), 0.5%BSA, 50%Glycerol. Preservative: 0.05% Sodium Azide. |
| 研究背景 | BLCAP is a highly conversed gene with two exons and an intron encoding a 10kDa protein, which was originally identified from invasive bladder carcinoma in 2002. BLCAP is subject to adenosine to inosine (A-to-I) RNA editing. A-to-I RNA editing is an important post-transcription modification of RNA sequence, generating a diversity of RNA products different from the original DNA sequence. The adenosine deaminase acting on double-stranded RNA (ADAR) family of enzymes catalyze the conversion of adenosine (A) to inosine (I) in the double stranded RNA, and inosine is finally recognized as guanosine (G) in the process of mRNA translation. May regulate cell proliferation and coordinate apoptosis and cell cycle progression via a novel mechanism independent of both p53/TP53 and NF-kappa-B. |
| 偶联 | Unconjugated |
| 免疫原 | Peptide |
| Uniprot ID |
存储&运输
| 储存方式 | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| 运输方式 | Shipping with blue ice. |
计算器
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
SCI 文献
评论列表
预览
Related Tags: buy Anti-BLCAP Antibody (7F556) | purchase Anti-BLCAP Antibody (7F556) | Anti-BLCAP Antibody (7F556) cost | order Anti-BLCAP Antibody (7F556)
嗨！有任何问题？点我咨询
评论内容